Oslo Business Memo



[press release] Genomar Genetics appoints new CEO: Alejandro Tola Alvarez.

Alejandro Tola Alvarez

Alejandro Tola Alvarez

Alejandro Tola Alvarez has been appointed as the new Chief Executive Officer of Genomar Genetics, an EW Group company targeting the development and distribution of improved genetics for the rapidly developing tilapia industry.


He comes from a position as Chief Technical Officer and startedin his new role on 1. June 2017. He will be responsible for executing the company´s strategy on innovation, operations and business development, working with the company teams and customers as well as other organizations in EW Group. 


Alejandro has been part of the Genomar group since 2006 being based in South-East Asia as Chief Operational Officer and in Norway as Chief Technical Officer. 


“We are very pleased to find a highly qualified internal candidate for the CEO position”, says chairman Odd Magne Rødseth. Alejandro has played a major role in both R&D and commercial development of the most reputable and professional genetic brands in global tilapia aquaculture. He comes with a deep understanding of the tilapia operating environments and the opportunities of modern breeding technologies such as genomics to improve economic and environmental performance of the industry. 


Alejandro is educated as Dr. vet. med. and has obtained master’s degrees in the areas of aquaculture and business administration.


GenoMar Genetics, based in Oslo, Norway with main operation in Luzon, Philippines has developed the Genomar Supreme Tilapia strain (GST) through more than 25 years of professional and innovative selective breeding. The GST program is the direct continuation of the GIFT program and has a long-termassociation with Central Luzon State University. With a total of 50 employees in Philippines, Malaysia and other countries, the company has an excellent reputation for its consistent investment in breeding and the quality of its products. GenoMar Genetics was part of the Norway Fresh Group until March 2017 when EW GROUP, concluded an agreement to acquire 100% of the shares in GenoMar Genetics.


EW GROUP, based in Visbek, Germany, is a family-owned holding company with more than 120 subsidiaries in over 30 countries. The core business of the group is animal breeding, animal nutrition and animal health. EW GROUP employs more than 9,000 people worldwide. Over the last 10 years EW GROUP expanded into the aquaculture sector and includes companies like AquaGen, Aquabel, GenoMar Genetics and Vaxxinova.



Oslo, Norway June 5th 2017


Contact person:

Odd Magne Rødseth, Group Director aquaculture, EW GROUP Mail: odd.magne.rodseth@ew-group.de  phone: + 47 97 01 74 50